Discrepancy between the recommendations and reimbursement regulations of the anti-CGRPs in the Nordics

Session 5: Different reimbursement strategies of anti-CGRP monoclonal antibodies in Nordic countries – a clinical or political decision?

Lars Bendtsen

Associate Professor, University of Copenhagen, Rigshospitalet-Glostrup, Denmark